Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC) [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating the safety and efficacy of curcumin in patients with primary sclerosing cholangitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: John E. Eaton | Conditions: Primary Sclerosing Cholangitis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-01-18